+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

Breast Cancer Monoclonal Antibodies Market 2024-2028 - Product Thumbnail Image

Breast Cancer Monoclonal Antibodies Market 2024-2028

  • Report
  • July 2024
  • 182 Pages
  • Global
From
From
From
From
From
From
From
From
From
Uterine Fibroids Pipeline Analysis Report - Product Thumbnail Image

Uterine Fibroids Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • March 2025
  • 88 Pages
  • Global
Hormone Replacement Therapy Market Outlook, 2029 - Product Thumbnail Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • April 2024
  • 192 Pages
  • Global
From
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more